for Sep 20, 2019
What do you think about 🏥🖥 institutional screensavers as a tool to 🗣 spread #antimicrobialstewardship messages?... This one from Dr. Spellberg et al is pretty darn good. Looking forward to 📄🤓 reading about it when… https://t.co/4BXjqZLO94
— Bug Pharmacist 💊🦠 Tim Gauthier (@IDstewardship) September 20, 2019
'Tractable targets for meropenem-sparing antimicrobial stewardship interventions' JAC-Antimicrobial Resistance (JAC-AMR), Volume 1, Issue 2, September 2019 #JACAMRNews https://t.co/8Mm4T91Woa
— Antibiotic Action (@TheUrgentNeed) September 20, 2019
“Antimicrobial resistance is a really big threat [around the world] and animal agriculture clearly has an important role to play,” @pewhealth’s Karin Hoelzer says of a new global analysis of #antibioticresistance in animals. https://t.co/5ihEBdPMIs @KatherineJWu Via @novapbs
— Save Antibiotics (@saveantibiotics) September 20, 2019
🅸🅲🆈🅼🅸: UT Dallas microbiologists are discovering the tricks bacteria play to evade antibiotics and developing new strategies to fight infectious diseases
— UT Dallas (@UT_Dallas) September 20, 2019
—https://t.co/84oClhjGED pic.twitter.com/C2izxTogY8
'Quack pharmacists in Cambodia are fuelling the rise of drug-resistant bacteria by incorrectly peddling antibiotics, a study has found' #StopSuperbugs https://t.co/Bh2w0lUo6C
— Antibiotic Action (@TheUrgentNeed) September 20, 2019
Machine learning and AI are the exciting future of ID
— Antibiotic Steward (@ABsteward) September 20, 2019
NEW🔥 @CMIJournal
Machine learning for clinical decision support in infectious diseases:A narrative review of current applications
@AHolmesID @TmRawson @RahAhmad @pgeorgiou_ic @BRCinfection
#IDTwitter https://t.co/pRJ1lkPi9D pic.twitter.com/z5b0RINCvi
As November is approaching, we’ll be happy to see you at #WorldAMRCongress looking at the challenges and opportunities in #antibiotic R&D, #diagnostics, #antimicrobial stewardship, manufacturing, and infection control.
— AMR IndustryAlliance (@AMRAlliance) September 20, 2019
Meet you there! 👉 https://t.co/pU0uljM8br pic.twitter.com/EMOIvFowoV
New online: Long-term immunity against yellow fever in children vaccinated during infancy: a longitudinal cohort study https://t.co/95K28BPTbH #YellowFever
— The Lancet Infectious Diseases (@TheLancetInfDis) September 20, 2019
Our next seminar is on Tuesday, 24 September - implementation research principles and methods, and challenges in implementation of antimicrobial stewardship: https://t.co/O5tpnDuKHz pic.twitter.com/bZdLN0HkGH
— NCAS_Australia (@NCAS_Aus) September 20, 2019
C. diff causes more than 450,000 infections each year and the bacteria can be difficult for hospitals to get rid of. That’s where Angus, a 5-year-old English springer spaniel, comes in. https://t.co/n0fukKEqra @cvdall via @CIDRAP #saveabx
— Save Antibiotics (@saveantibiotics) September 20, 2019
Antimicrobial Stewardship in a Hematological Malignancy Unit: Carbapenem Reduction and Decreased Vancomycin-resistant Enterococcus Infection https://t.co/ELXX38e0MQ
— GEIRAS/GEIH (SEIMC) (@GEIRAS_SEIMC) September 20, 2019
#antibiotics that farmers use to prevent illness in animals are losing effectiveness as bacteria develop #AntibioticResistance.
— Microbes&Infection (@MicrobesInfect) September 20, 2019
The resistant bacteria could travel to people, creating untreatable infections, & they harm farmers’ ability to raise animals.https://t.co/C0qvCoWxN8 pic.twitter.com/35DP965qBz
Clear increase in levels of antibiotic resistance in pigs and poultry in low and middle-income countries, with potential consequences for human and animal health. Growing meat consumption and routine antibiotic use in intensive farming behind the trend https://t.co/7yfYB42HLh
— Save our Antibiotics (@ASOAntibiotics) September 20, 2019
In our commitment to #KeepAntibioticsWorking, we’ve invested in several #AntiMicrobial stewardship initiatives. Read more in #Pfizercolleague Claudie Charbonneau's blog published
— Pfizer EU Policy (@PfizerEUPolicy) September 20, 2019
by @EFPIA 🇪🇺 #AMRhttps://t.co/5uVcYLOWUV pic.twitter.com/SKeRGOmZ3q
Extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae from urinary tract infections: Evolution of antimicrobial resistance and treatment options. https://t.co/CYNfR0s7TY
— AntibioticResistance (@AntibioticResis) September 20, 2019
'Increasing global antibiotic resistance in food animals requires immediate action' #StopSuperbugs #AntibioticFootprint #OneHealth https://t.co/zgmebdOJGl via @cddep @EurekAlert
— Antibiotic Action (@TheUrgentNeed) September 20, 2019
New: In this cluster randomized trial, electronic medication reconciliation reduced medication discrepancies but had *no effect* on adverse drug events (primary outcome), emergency department visits, or 30-day readmissions. @JAMANetworkOpen https://t.co/PXfMBqABOe
— 𝙀𝙡𝙞 𝙋𝙚𝙧𝙚𝙣𝙘𝙚𝙫𝙞𝙘𝙝 😷 (@eliowa) September 20, 2019
Waning of #Influenza Vaccine Protection: Exploring the Trade-offs of Changes in Vaccination Timing Among Older Adults | Clinical Infectious Diseases | Oxford Academic https://t.co/H2P5hV9Vri
— onisillos sekkides 🦠 (@onisillos) September 20, 2019
$570bn=the estimated annual global cost of pandemics 🦠
— CEPI (@CEPIvaccines) September 20, 2019
$2.8bn=estimated cost for one vaccine against each of @WHO 11 priority epidemic infectious diseases, from our research in @LancetGH #VaccinesWork to #OutsmartEpidemics 👉https://t.co/R4GgA4MSph pic.twitter.com/4cSFWnjKR8
In @ICHEJournal, researchers reviewed the use of social media platforms to increase the reach of critical research on infection prevention, hospital epidemiology & antimicrobial stewardship. More info in Q&A w/ @KellyCawcuttMD: https://t.co/itO1t1dGvA #hcsm #hcsmR @InfectDisNews
— Lily Vautour, MBA (@LilyVautour) September 20, 2019
Diagnostic accuracy of serum (1,3)-Beta-D-Glucan for neonatal invasive candidiasis: systematic review and meta-analysis. Looks like a good rule-out test? https://t.co/s2EH5DBx9Z
— Abid Hussain (@MicrobLog_me_uk) September 20, 2019
“Waterways with lots of human activity may serve as incubators of bacterial resistance.” https://t.co/DtqSUiYof9 @forbes
— Save Antibiotics (@saveantibiotics) September 20, 2019
Latest tour de force, must-read paper from @thvanboeckel, @CDDEP ‘s Ramanan Laxminarayan & colleagues uses PPS & geospatial mapping to demonstrate global trends in #AMR in food production animals. Important global & national policy & funding messages https://t.co/bLG0cwXs6V
— Marc Mendelson (@SouthAfricanASP) September 20, 2019
Very important point. NIH (arlg) *does not* fund infection control or antimicrobial stewardship studies. This needs to change. https://t.co/qHJVj5lkFW
— 𝙀𝙡𝙞 𝙋𝙚𝙧𝙚𝙣𝙘𝙚𝙫𝙞𝙘𝙝 😷 (@eliowa) September 20, 2019
Check out Hannah’s recent “Editor’s Choice” editorial in Journal of Infectious Diseases! https://t.co/7nArPShEIc @McMasterIIDR @MacImmunology
— Miller Lab (@Millerlab_atMac) September 20, 2019
Deadline to submit your abstract for the 19th ICID is OCTOBER 25th! @ISID_org invites submissions of abstracts of excellent quality in all areas related to infectious diseases. 900+ abstracts will be presented. #ICID2020 #infectiousdiseases https://t.co/RbG8gudVuk pic.twitter.com/Oa2n1KUJYn
— Marc Mendelson (@SouthAfricanASP) September 20, 2019
In @PLOS @PLOSNTDs @PeterHotez @JacksonLeeTX18 write how #Texas + US #GulfCoast is a distressed area and highly vulnerable to tropical infectious diseases due to #poverty #ClimateChange catastrophic weather events, which are now increasingly common https://t.co/JGIufooi6d
— Prof Peter Hotez MD PhD (@PeterHotez) September 20, 2019
C. difficile whole-genome sequencing reveals limited within-host genetic diversity in a pediatric cohort @Jclinmicro https://t.co/DkZQSSVlF1 #ASMClinMicro pic.twitter.com/OvAXwrA9nd
— ASM (@ASMicrobiology) September 20, 2019
An executive order has been signed by @realDonaldTrump for developing better #influenza vaccines. IDSA spokesperson Andrew Pavia, MD (@AndrewPaviaMD) says the order is "an important and clear commitment to goals" in preventing influenza. https://t.co/aQxrGRpZm7 #VaccinesWork
— IDSA (@IDSAInfo) September 20, 2019
The best way to protect against #flu is to #GetVaccinated each year. Flu vaccination is recommended annually for everyone age 6 months and older via @CDCgov #FightFlu https://t.co/UuY5SYeO3z pic.twitter.com/CcwPsHAzdu
— NFID (@NFIDvaccines) September 20, 2019
Breaking News 📢📢@Merck
— Antibiotic Steward (@ABsteward) September 20, 2019
Merck’s PIFELTRO™ (doravirine) $ DELSTRIGO™ (doravirine/lamivudine/tenofovir disoproxil fumarate) Receive US FDA Approval for Use in Appropriate Adults Living with HIV-1 Who Are Virologically Suppressed. #IDTwitter https://t.co/kW1qWaj0dZ pic.twitter.com/9svMM4NAVp
Have you been waiting for a chance to challenge your ID friends in trivia? Don’t miss out on your opportunity with ID Trivia hosted by @penicillinman Doug Slain at the #SIDP2019 Annual Meeting in Wash DC Oct 1. Always entertaining and very competitive! https://t.co/XxujUK1VSS pic.twitter.com/bBaSzIszId
— SIDP (@SIDPharm) September 20, 2019
Parts of our research — at @uclcs and the @isenseIRC — on modelling infectious diseases, and #flu in particular, from online search data have been featured in this outlook article by @nature. #AI #healthhttps://t.co/KVqxFhFAtJ pic.twitter.com/sW8ZEzMSFg
— Bill Lampos (@lampos) September 20, 2019
Antibiotic resistance in animals tied to global hot spots https://t.co/usli2BHyOS #AMR #AntibioticStewardship pic.twitter.com/I5K4hZPaTK
— CIDRAP (@CIDRAP) September 20, 2019
Cardiovirus leader proteins prevent double-stranded RNA detection by PKR to interfere with innate cell responses @Jvirology https://t.co/5d72SAkUQU pic.twitter.com/KldY3JZ6v8
— ASM (@ASMicrobiology) September 20, 2019
From virus to #vaccine: Studying #measles immunity https://t.co/LVxrF4lN5R via @medlineplus #PreventMeasles pic.twitter.com/ElVHPsShch
— NFID (@NFIDvaccines) September 20, 2019
> 10 persons have died of Crimean-Congo Hemorrhagic fever in Iran since the beginning of the current Iranian calendar year (March 21).
— Microbes&Infection (@MicrobesInfect) September 20, 2019
106 people have been diagnosed with the disease but survived after undergoing treatment.https://t.co/6p32Y5L3qT #CCHF pic.twitter.com/K9qJ7LZ2Np
Graciela Lorca studies genetic systems to find microbial interactions that affect disease. She talks about her work on the citrus greening disease bacterium, L. asiaticus, and the role of probiotic L. johnsonii in diabetes. Download or stream today: https://t.co/IaFJ5yI41y
— ASM (@ASMicrobiology) September 20, 2019
Plus linked Comment: Are booster doses of yellow fever vaccine needed? https://t.co/tGOVdiIaGJ #YellowFever
— The Lancet Infectious Diseases (@TheLancetInfDis) September 20, 2019
September and October are perfect times to get the #FluShot, says Paul Sax, MD, Clinical Director of the Division of Infectious Diseases at Brigham. More on @WCVB: https://t.co/MQpZmRlvUj
— Brigham and Women's (@BrighamWomens) September 20, 2019
Submit your abstract for the 19th ICID by OCTOBER 25th! @ISID_org invites submissions of abstracts of excellent quality in all areas related to infectious diseases. 900+ abstracts will be presented. #ICID2020 #infectiousdiseases icid.isid.or https://t.co/b8Nsyr2HJy
— Esmita Charani (@e_charani) September 20, 2019
Staff raised no objections & 2 months in inpatient urine cultures are down >33%. We want more. We’re starting to send around monthly assessments of appropriateness of inpt urine cultures by service. We will be publishing all this when it’s said and done. Need >6 more mos data.
— Brad Spellberg (@BradSpellberg) September 20, 2019
The Wilcox Lab (@kswilcox) is looking for a highly motivated #postdoc! Help work on basic #epilepsy research and therapy development in the @uofupharmacy. https://t.co/brvmi7mXmP #ECRchat #PhdChat #AcademicTwitter #ScienceJobs #Research #Neuroscience pic.twitter.com/LYJd4pEHNo
— UofU3i (@UofU3i) September 20, 2019
Changing the ratio of adjuvant to antibiotic appears to slow and steer the path of resistance evolution, lending support to using increased adjuvant dosing regimens to slow the rate of resistance evolution @mbiojournal https://t.co/nFonRMKrDx
— ASM (@ASMicrobiology) September 20, 2019
Excellent paper just published in @NatureComms sheds lights on why #males are more susceptible to infectious diseases yet #females have higher rates of autoimmune diseases. https://t.co/J7YHZn4R2F#sexdifference #SABV @CdnImmunol
— Jenna Haverfield, PhD (@JennaHaverfield) September 20, 2019
Short-course Antibiotic Therapy: A Bespoke Approach Is Required | Clinical Infectious Diseases | Oxford Academic https://t.co/OEKqBQXDns
— onisillos sekkides 🦠 (@onisillos) September 20, 2019
For gut microbes, not all types of #fiber are created equal.
— Microbes&Infection (@MicrobesInfect) September 20, 2019
A screen identified food-grade fibers that selectively affect different Bacteroides species. In pea fiber, active molecules include arabinan, but homogalacturonan in citrus pectin.https://t.co/L3RahWedfq #microbiota pic.twitter.com/HOyTLKLjr1
This is why the @FIP_org workshop on #antimicrobialstewardship we are running on Sunday at World Pharmacy Congress is so important #fip ##fip2019 @idpharmd @EssackSabiha @wellcometrust @WHO @uniacgamr @CMO_England https://t.co/MYTJ1ED0xx
— Philip Howard (@AntibioticLeeds) September 20, 2019
This 1gets it! research➡️ publish➡️ repeat and repeat and repeat! Keep going @TheIDApprentice Were proud of you ! @TheBack140 @real_idpharmd @StewardshipJAX pic.twitter.com/1Men8gvEMy
— Debbie Goff (@idpharmd) September 20, 2019
Control and Elimination of Extensively Drug-Resistant Acinetobacter baumanii in an Intensive Care Unit - Volume 25, Number 10—October 2019 - Emerging Infectious Diseases journal - CDC https://t.co/DfSFEgoWtC via @CDCgov
— gabriel birgand (@GBirgand) September 20, 2019
"A broken commercial model for antibiotics and a pharmacy budget driven approach to stewardship, ... is stifling investment and innovation in novel antibiotic R&D resulting in the real threat of the future returning to the pre-antibiotic era." https://t.co/sE99HLxfJ8
— Abid Hussain (@MicrobLog_me_uk) September 20, 2019
The Role of Antimicrobial Restrictions in Bacterial Resistance Control: A Systematic Literature Review https://t.co/Lzxf3lpdE0
— Abid Hussain (@MicrobLog_me_uk) September 20, 2019
🔥 take: can we stop branding everything ____ stewardship? Antimicrobials are a shared resource and inappropriate use drives resistance and limits their utility for society. That's not true of most other things the term is being applied to. @JGPharmD @mmPharmD @EB_Hirsch
— Brandon Dionne (@BWDionne) September 20, 2019
Thanks for the hard work of many experts who worked behind the scenes to develop an agenda to accelerate development of more effective, rapidly producable and scalable flu vaccine. Trump Orders Flu Vaccine Overhaul https://t.co/wOIG9gs7lB
— Andrew Pavia (@AndrewPaviaMD) September 20, 2019
Created by Cameron Forbes. Last updated September 21, 2019 at 05:13 EST.